Torren Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Torren Management's RPRX Position: Q2 2026 in Review
Torren Management held its Royalty Pharma (RPRX) position steady in Q2 2026 at 285 shares worth $16K. The position accounts for 0.01% of the portfolio, ranked #164.
Torren Management first reported a position in RPRX in Q4 2025 and has held it in 3 quarters since. 296 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.
- Torren Management held 285 shares of Royalty Pharma worth $16K as of Q2 2026.
- Torren Management left its Royalty Pharma share count unchanged in Q2 2026.
- Royalty Pharma made up 0.01% of Torren Management's portfolio in Q2 2026, its #164 holding.
- Torren Management first reported a position in Royalty Pharma in Q4 2025 and has held it in 3 quarters since.
- 296 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.
Based on Torren Management's 13F filing for Q2 2026, filed 10 Jul 2026.